In managing a child with Kawasaki disease, which of the following is the primary purpose of administering intravenous immunoglobulin (IVIG)?

A) To reduce the risk of coronary artery aneurysms

B) To directly lower elevated white blood cell counts

C) To provide immediate relief from skin rashes

D) To eliminate the underlying viral cause of the disease

A 5-year-old male has been diagnosed with Kawasaki disease. Which of the following nursing interventions is a priority in the initial management of this child?

C) Administering intravenous immunoglobulin (IVIG) therapy

A) Initiating intravenous fluids to maintain hydration

B) Monitoring for signs of coronary artery complications

C) Administering intravenous immunoglobulin (IVIG) therapy

D) Encouraging ambulation to prevent joint stiffness

What is the primary reason for administering aspirin to a child diagnosed with Kawasaki disease?

B) To prevent coronary artery complications

D) To decrease swelling in extremities

What is the primary purpose of administering aspirin to a child recovering from Kawasaki disease?

B) To prevent coronary artery complications

Which of the following actions should the nurse prioritize when a child on aspirin therapy for Kawasaki disease shows mild gastrointestinal discomfort?

B) Monitor for signs of gastrointestinal bleeding

A) Discontinue aspirin immediately

B) Monitor for signs of gastrointestinal bleeding

C) Increase aspirin dosage to manage symptoms

D) Ignore symptoms as they are common and harmless

When caring for a child with Kawasaki disease who is experiencing mild gastrointestinal discomfort, what is the most appropriate nursing intervention?

C) Reinforce the adjusted aspirin dosage regimen and monitor for changes

A) Encourage the child to take aspirin on an empty stomach

B) Advise the parents to discontinue aspirin therapy immediately

C) Reinforce the adjusted aspirin dosage regimen and monitor for changes

D) Suggest increasing fluid intake to alleviate gastrointestinal symptoms

What is the primary reason for monitoring liver enzyme levels in a child receiving aspirin therapy for Kawasaki disease?

B) To detect potential hepatotoxicity

C) To evaluate cardiac function

D) To monitor for signs of dehydration

Which of the following assessments is most important to perform regularly in a child recovering from Kawasaki disease who is on aspirin therapy?

C) Checking for signs of gastrointestinal bleeding

What is the primary reason for monitoring the coronary arteries in a child recovering from Kawasaki disease?

A) To detect potential coronary artery aneurysms

B) To ensure adequate oxygen saturation levels

C) To assess the child's blood pressure stability

D) To evaluate respiratory function during exertion

What is the primary rationale for monitoring the child with Kawasaki disease for coronary artery changes?

B) To identify potential coronary artery aneurysms

A) To prevent the development of arrhythmias

B) To identify potential coronary artery aneurysms

C) To reduce the risk of respiratory complications

D) To ensure normal growth and development

kawasaki - Nursing Case Study

Pathophysiology

• Primary mechanism: Kawasaki disease is primarily an inflammatory process affecting the blood vessels, particularly the coronary arteries. This inflammation can lead to swelling and damage within the vessel walls, increasing the risk of aneurysms.

• Secondary mechanism: The disease triggers an autoimmune response, where the body's immune system mistakenly attacks its own blood vessels. This response further aggravates the inflammation and contributes to the clinical symptoms such as fever, rash, and swollen lymph nodes.

• Key complication: If untreated, the inflammation can lead to coronary artery aneurysms, which are serious because they can result in blood clots, heart attacks, or long-term heart damage in children. Early diagnosis and treatment with medications like IVIG and aspirin are crucial to prevent these complications.

Patient Profile

Demographics:

5-year-old male, kindergarten student

History:

• Key past medical history: No significant past medical history

• Current medications: None

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Prolonged fever for 5 days

• Key symptoms: Fever, conjunctival injection, rash on trunk, red and cracked lips, swollen hands and feet

• Vital signs: Temperature 38.5°C, heart rate 110 bpm, respiratory rate 22 breaths per minute, blood pressure 90/60 mmHg

Section 1

Initial Assessment Findings:

Upon further assessment, the 5-year-old male presents with additional symptoms that align with the typical clinical presentation of Kawasaki disease. His oral mucosa is bright red, and he exhibits a "strawberry tongue." The child's cervical lymph nodes are palpable and slightly tender, consistent with mild lymphadenopathy. Physical examination reveals erythematous rash predominantly on the trunk, which has not spread significantly to other body areas. The patient's hands and feet remain swollen, and there is slight peeling of the skin around the fingertips, indicating early desquamation. His conjunctiva continues to show bilateral, non-purulent injection without discharge.

Laboratory findings further support the diagnosis. Blood tests reveal an elevated white blood cell count, indicative of systemic inflammation, and a significantly increased erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), both of which are markers of acute inflammation. Platelet levels are slightly elevated, which is common in the later stages of Kawasaki disease as the body responds to inflammation. Echocardiogram results show no evidence of coronary artery aneurysms at this early stage, suggesting that the disease has not yet progressed to more severe cardiovascular involvement.

The nursing team focuses on monitoring the child's vital signs closely, particularly heart rate and blood pressure, to detect any early signs of cardiovascular strain. Hydration status is assessed regularly due to the patient's fever and potential for dehydration. The plan includes initiating intravenous immunoglobulin (IVIG) therapy and aspirin to reduce inflammation and prevent coronary complications. Education for the parents on the importance of medication adherence and signs of potential complications, such as increased irritability or shortness of breath, is also prioritized to prepare for ongoing care and follow-up.

Section 2

Response to Interventions:

Following the administration of intravenous immunoglobulin (IVIG) and aspirin, the 5-year-old patient begins to show signs of clinical improvement. Within 48 hours of starting the treatment, his fever subsides, and he appears more comfortable and less irritable. The erythematous rash on his trunk starts to fade, and there is a noticeable reduction in the swelling of his hands and feet. The nursing team continues to monitor his vital signs closely, observing a stable heart rate and blood pressure, which remain within age-appropriate ranges. His hydration status is carefully managed with oral fluids, and he is encouraged to drink small, frequent sips to maintain adequate fluid intake.

Laboratory results are repeated to assess the response to treatment. The white blood cell count begins to normalize, and both the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels show a downward trend, indicating a reduction in systemic inflammation. Platelet levels, although still elevated, are expected to peak before gradually decreasing as part of the natural course of the disease. The nursing team reinforces the importance of continued aspirin therapy to the parents, emphasizing its role in preventing coronary artery complications.

Education efforts with the family are ongoing, focusing on recognizing signs of potential complications, such as persistent fever beyond 48 hours after IVIG treatment or any new symptoms that may arise. The parents are advised to maintain regular follow-up appointments with the pediatrician and cardiologist to monitor the child's progress and ensure early detection of any cardiovascular issues. This proactive approach aims to support the child's recovery and prevent long-term complications associated with Kawasaki disease.

Section 3

New Complications:

Despite the initial positive response to treatment, the nursing team notices that the patient begins to exhibit mild gastrointestinal discomfort, characterized by intermittent abdominal pain and a slight decrease in appetite. The parents also report that the child has been experiencing some nausea, although he has not vomited. These symptoms prompt further assessment by the healthcare team to ensure no significant gastrointestinal complications are developing. The nursing team conducts a thorough abdominal assessment, finding the abdomen soft and non-tender, with normal bowel sounds. Vital signs remain stable, with a temperature of 37.2°C (99°F), heart rate at 90 bpm, respiratory rate at 20 breaths per minute, and blood pressure at 95/60 mmHg, all within normal limits for the child's age.

Laboratory tests are ordered to rule out any secondary complications. Results show a mild elevation in liver enzymes, which is not uncommon during aspirin therapy but requires close monitoring. The white blood cell count is within normal limits, and the ESR and CRP continue to trend downward, supporting the overall improvement in the inflammatory process. The platelet count remains elevated but stable, consistent with the typical course of Kawasaki disease during this phase. In response to the gastrointestinal symptoms, the healthcare team decides to adjust the aspirin dosage slightly, ensuring the therapeutic effect is maintained while minimizing potential side effects.

The nursing team provides reassurance to the parents, explaining the potential for mild gastrointestinal side effects from aspirin and the importance of adherence to the adjusted dosing regimen. They emphasize the need to continue monitoring the child for any changes in symptoms, such as increased abdominal pain or signs of gastrointestinal bleeding, like dark stools. With the collaborative efforts of the healthcare team and the family, the child’s care plan is adjusted to support ongoing recovery while addressing these minor complications, setting the stage for continued improvement and monitoring for any further changes in the child's condition.

Section 4

As the days progress, the nursing team continues to monitor the child closely, focusing on the response to the adjusted aspirin dosage. The child's gastrointestinal discomfort begins to subside, with the nursing team noting an improvement in appetite and a reduction in reports of nausea. The parents express relief as their child resumes eating more normally, and the abdominal pain becomes less frequent and intense. Regular abdominal assessments continue to show a soft, non-tender abdomen with active bowel sounds, further indicating that the initial concerns about potential gastrointestinal complications are being effectively managed.

To ensure comprehensive care, the healthcare team orders follow-up laboratory tests. The results reveal that liver enzyme levels have stabilized, alleviating concerns of aspirin-induced hepatotoxicity. The inflammatory markers, ESR and CRP, continue to decrease steadily, reinforcing the positive trajectory of the child's recovery from Kawasaki disease. The platelet count, while elevated, remains stable, consistent with the expected clinical course. With these reassuring findings, the healthcare team provides feedback to the parents, explaining that the current treatment plan is effectively addressing the child's condition and that ongoing monitoring will continue to ensure no new complications arise.

The focus now shifts to supporting the child’s gradual return to normal activities while maintaining vigilance for any new symptoms. The nursing team educates the parents on signs of potential complications to watch for, such as increased fatigue or changes in skin color, and emphasizes the importance of follow-up appointments to monitor the child's cardiovascular health, given the risk of coronary artery involvement in Kawasaki disease. With the collaborative efforts of the healthcare team and the family, the child is on a promising path to recovery, with plans for ongoing assessments to guide any necessary adjustments in care. This careful management sets the stage for the child’s continued improvement and eventual recovery.

Section 5

As the child continues to recover, the nursing team remains attentive to the possibility of new complications, particularly concerning the cardiovascular system. During a routine follow-up assessment, the nurse notes that the child's activity tolerance has slightly decreased; the child appears more fatigued than usual after playing, and the parents mention noticing some mild shortness of breath during exertion. Vital signs indicate a slight increase in heart rate to 120 beats per minute, but blood pressure remains stable at 100/60 mmHg. Oxygen saturation levels are within normal limits at 98%, and there are no signs of cyanosis. These subtle changes prompt the healthcare team to conduct an echocardiogram to assess for any potential coronary artery involvement, a known risk associated with Kawasaki disease.

The echocardiogram results reveal a mild dilation of the right coronary artery, a finding that, while not immediately alarming, requires careful monitoring. The healthcare team discusses these results with the parents, explaining the significance of coronary artery changes in Kawasaki disease and the importance of continued vigilance. They reassure the parents that the current treatment plan, including the adjusted aspirin dosage, is appropriate but emphasize the need for regular cardiovascular evaluations to track any changes in the child's condition. The team creates a follow-up schedule, including cardiology consultations, to ensure comprehensive ongoing care.

In response to these findings, the nursing team reviews and reinforces the education provided to the parents, highlighting the importance of pacing the child's activities to prevent undue fatigue and monitoring for any additional symptoms such as chest pain or more pronounced shortness of breath. This comprehensive approach ensures that the child remains on a path to recovery while minimizing the risk of long-term complications. The parents express gratitude for the thorough care and support, feeling more empowered to manage their child's health in partnership with the healthcare team. With these proactive measures in place, the child is well-positioned to continue progressing toward full recovery.